Cargando…

Receptor for Advanced Glycation End Products Is Involved in LPA(5)-Mediated Brain Damage after a Transient Ischemic Stroke

Lysophosphatidic acid receptor 5 (LPA(5)) has been recently identified as a novel pathogenic factor for brain ischemic stroke. However, its underlying mechanisms remain unclear. Here, we determined whether the receptor for advanced glycation end products (RAGE) could be involved in LPA(5)-mediated b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sapkota, Arjun, Park, Sung Jean, Choi, Ji Woong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910825/ https://www.ncbi.nlm.nih.gov/pubmed/33499230 http://dx.doi.org/10.3390/life11020080

Ejemplares similares

Inhibition of LPA(5) Activity Provides Long-Term Neuroprotection in Mice with Brain Ischemic Stroke
por: Sapkota, Arjun, et al.
Publicado: (2020)

NLRP3 Inflammasome Activation Is Involved in LPA(1)-Mediated Brain Injury after Transient Focal Cerebral Ischemia
por: Lee, Chi-Ho, et al.
Publicado: (2020)

BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
por: Gaire, Bhakta Prasad, et al.
Publicado: (2020)

Lysophosphatidic acid receptor 1 (LPA(1)) plays critical roles in microglial activation and brain damage after transient focal cerebral ischemia
por: Gaire, Bhakta Prasad, et al.
Publicado: (2019)

Oleanolic Acid Provides Neuroprotection against Ischemic Stroke through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation
por: Sapkota, Arjun, et al.
Publicado: (2022)

LPA(1), LPA(2), LPA(4), and LPA(6) receptor expression during mouse brain development
por: Suckau, Olga, et al.
Publicado: (2019)

Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism
por: Park, Hyun-Young, et al.
Publicado: (2009)

Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke
por: Rao, Nivedita L., et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
por: Chuah, Yaw Kuang, et al.
Publicado: (2013)

Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus
por: Filipov, Alexandra, et al.
Publicado: (2022)

Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Effect of transient cerebral ischemia on the expression of receptor for advanced glycation end products in the gerbil hippocampus proper
por: Cho, JH, et al.
Publicado: (2014)

Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
por: Gad, Hoda, et al.
Publicado: (2019)

Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses
por: Sapkota, Arjun, et al.
Publicado: (2020)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014)

Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage
por: Kong, Xiang, et al.
Publicado: (2017)

Ethyl Pyruvate Prevents Renal Damage Induced by Methylglyoxal-Derived Advanced Glycation End Products
por: Jung, Eunsoo, et al.
Publicado: (2019)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
por: Lee, Hee-Weon, et al.
Publicado: (2021)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Correction: Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
por: Gad, Hoda, et al.
Publicado: (2019)

Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2
por: Knowlden, Sara A., et al.
Publicado: (2014)

Global Brain Perfusion and the Risk of Transient Ischemic Attack and Ischemic Stroke: The Rotterdam Study
por: Fani, Lana, et al.
Publicado: (2019)

Advanced glycation end-product (AGE)-albumin from activated macrophage is critical in human mesenchymal stem cells survival and post-ischemic reperfusion injury
por: Son, Myeongjoo, et al.
Publicado: (2017)

Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors
por: Yang, Yifan, et al.
Publicado: (2022)

Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
por: Hegab, Zeinab, et al.
Publicado: (2017)

Spatholobus suberectus Ameliorates Diabetes-Induced Renal Damage by Suppressing Advanced Glycation End Products in db/db Mice
por: Do, Moon Ho, et al.
Publicado: (2018)

Correlation between Lpa, APO-A, APO-B, and Stenosis of Middle Cerebral Artery in Patients with Cerebral Ischemic Stroke
por: Chen, Xinxu, et al.
Publicado: (2022)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice
por: Charrin, Emmanuelle, et al.
Publicado: (2019)

Kuwanon G protects HT22 cells from advanced glycation end product-induced damage
por: Gan, Wen-Jun, et al.
Publicado: (2021)

Gintonin influences the morphology and motility of adult brain neurons via LPA receptors
por: Kim, Do-Geun, et al.
Publicado: (2021)

Neuroprotective Effects of Endogenous Secretory Receptor for Advanced Glycation End-products in Brain Ischemia
por: Shimizu, Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1b6a7q6rl0gbi5e5jfphv4asnv